13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 31 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

TVGN Stock Analysis & AI Quality Score

Data updated 2026-07-26

AI stock analysis and institutional research for Tevogen Inc. (TVGN), a Healthcare sector company. TVGN is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 31 institutional filers currently hold this stock. Top institutional holders of TVGN by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, MORGAN STANLEY, AQR CAPITAL MANAGEMENT, based on the most recent SEC filings. TVGN trades on the Nasdaq exchange and files with the SEC under CIK 1860871. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TVGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tevogen Inc. directly from SEC EDGAR.

Net Income

Q2 2026

$-5.8M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Net Income

-91.4% YoY
$-26.3MFY 2025
FY22 $4.4MFY23 $-60.5MFY24 $-13.7MFY25 $-26.3M

Operating Income

+51.2% YoY
$-26.1MFY 2025
FY22 FY23 $-8.8MFY24 $-53.6MFY25 $-26.1M

EPS (Diluted)

-130.9% YoY
$-8.08FY 2025
FY22 FY23 $-2.44FY24 $-3.50FY25 $-8.08

Total Assets

+26.6% YoY
$4.4MFY 2025
FY22 $357.1MFY23 $5.5MFY24 $3.5MFY25 $4.4M

Total Debt

FY 2025
FY22 $0.00FY23 FY24 FY25

Op. Cash Flow

-2.7% YoY
$-12.3MFY 2025
FY22 $-215.4KFY23 $-8.2MFY24 $-12.0MFY25 $-12.3M

Free Cash Flow

$-12.4MFY 2025
FY22 FY23 $-8.3MFY24 FY25 $-12.4M

Get alerted when TVGN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Tevogen Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of TVGN

Put TVGN on your watchlist

Track score changes the day Tevogen Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is TVGN a good stock to buy?

13F Pro's AI-powered analysis of Tevogen Inc. (TVGN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TVGN are available on the TVGN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. TVGN is classified as a small company.

Which hedge funds own TVGN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TVGN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Tevogen Inc.'s investment landscape.